Literature DB >> 18339348

Paraneoplastic syndromes of the CNS.

Josep Dalmau1, Myrna R Rosenfeld.   

Abstract

Major advances in the management of paraneoplastic neurologic disorders (PND) include the detection of new antineuronal antibodies, the improved characterisation of known syndromes, the discovery of new syndromes, and the use of CT and PET to reveal the associated tumours at an early stage. In addition, the definition of useful clinical criteria has facilitated the early recognition and treatment of these disorders. In this article, we review some classic concepts about PND and recent clinical and immunological developments, focusing on paraneoplastic cerebellar degeneration, opsoclonus-myoclonus, and encephalitides affecting the limbic system.

Entities:  

Mesh：

Year:  2008        PMID： 18339348      PMCID： PMC2367117          DOI： 10.1016/S1474-4422(08)70060-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


  136 in total

1.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

2.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

3.  Opsoclonus-myoclonus associated with celiac disease.

Authors:  Nicolas Deconinck; Michèle Scaillon; Valérie Segers; José J Groswasser; Bernard Dan
Journal:  Pediatr Neurol       Date:  2006-04       Impact factor: 3.372

4.  Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy.

Authors:  C E Fadul; E W Stommel; K H Dragnev; C J Eskey; J O Dalmau
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

5.  Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders

Authors: 
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

6.  Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

Authors:  F A Luque; H M Furneaux; R Ferziger; M K Rosenblum; S H Wray; S C Schold; M J Glantz; K A Jaeckle; H Biran; M Lesser
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

7.  Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.

Authors:  Rainer Linke; Mira Schroeder; Thomas Helmberger; Raymond Voltz
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

8.  Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.

Authors:  P M Candler; R C Dale; S Griffin; A J Church; R Wait; M D Chapman; G Keir; G Giovannoni; J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

9.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

Authors:  J H O'Neill; N M Murray; J Newsom-Davis
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

10.  Clinical analysis of anti-Ma2-associated encephalitis.

Authors:  Josep Dalmau; Francesc Graus; Alberto Villarejo; Jerome B Posner; Deborah Blumenthal; Brian Thiessen; Albert Saiz; Patricio Meneses; Myrna R Rosenfeld
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501
View more
  212 in total

1.  Paraneoplastic pandysautonomia as a manifestation of non-small cell lung cancer.

Authors:  Kayihan Uluc; Muge Kocak; Pinar Kahraman Koytak; Deniz Borucu; Baris Isak; Sevinc Aktan; Onder Us
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

Review 2.  Neurologic complications of cancer and its treatment.

Authors:  Pierre Giglio; Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

Review 3.  Rhombencephalitis / brainstem encephalitis.

Authors:  Burk Jubelt; Cornelia Mihai; Terrence M Li; Padma Veerapaneni
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

Review 4.  Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Authors:  Emilia H Moscato; Ankit Jain; Xiaoyu Peng; Ethan G Hughes; Josep Dalmau; Rita J Balice-Gordon
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

Review 5.  Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature.

Authors:  Joe Puthenparambil; Klaus Lechner; Gabriela Kornek
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

6.  Pearls & Oy-sters: Limbic encephalitis associated with positive anti-LGI1 and antithyroid antibodies.

Authors:  Sheng-Jun Wang; Yu-Ying Zhao; Qin-Zhou Wang; Bin Guo; Yi-Ming Liu; Chuan-Zhu Yan
Journal:  Neurology       Date:  2016-01-12       Impact factor: 9.910

7.  The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.

Authors:  Mary S Gable; Heather Sheriff; Josep Dalmau; Drake H Tilley; Carol A Glaser
Journal:  Clin Infect Dis       Date:  2012-01-26       Impact factor: 9.079

8.  Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis.

Authors:  Simone M Brändle; Manuela Cerina; Susanne Weber; Kathrin Held; Amélie F Menke; Carmen Alcalá; David Gebert; Alexander M Herrmann; Hannah Pellkofer; Lisa Ann Gerdes; Stefan Bittner; Frank Leypoldt; Bianca Teegen; Lars Komorowski; Tania Kümpfel; Reinhard Hohlfeld; Sven G Meuth; Bonaventura Casanova; Nico Melzer; Eduardo Beltrán; Klaus Dornmair
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

9.  Limbic encephalitis and related cortical syndromes.

Authors:  Ignacio Rubio-Agusti; Miguel Salavert; Luis Bataller
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

10.  18 F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET Access Program, with systematic review and meta-analysis.

Authors:  C Harlos; U Metser; R Poon; P MacCrostie; W Mason
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.